Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 05 04 2020
accepted: 10 08 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 13 1 2021
Statut: epublish

Résumé

Anthroponotic cutaneous leishmaniasis (CL) caused by Leishmania tropica (L. tropica) represents a public health challenge in several resource poor settings. We herein employed a systems analysis approach to study molecular signatures of CL caused by L. tropica in the skin lesions of ulcerative CL (UCL) and non-ulcerative CL (NUCL) patients. Results from RNA-seq analysis determined shared and unique functional transcriptional pathways in the lesions of the UCL and NUCL patients. Several transcriptional pathways involved in inflammatory response were positively enriched in the CL lesions. A multiplexed inflammatory protein analysis showed differential profiles of inflammatory cytokines and chemokines in the UCL and NUCL lesions. Transcriptional pathways for Fcγ receptor dependent phagocytosis were among shared enriched pathways. Using L. tropica specific antibody (Ab)-mediated phagocytosis assays, we could substantiate Ab-dependent cellular phagocytosis (ADCP) and Ab-dependent neutrophil phagocytosis (ADNP) activities in the lesions of the UCL and NUCL patients, which correlated with L. tropica specific IgG Abs. Interestingly, a negative correlation was observed between parasite load and L. tropica specific IgG/ADCP/ADNP in the skin lesions of CL patients. These results enhance our understanding of human skin response to CL caused by L. tropica.

Identifiants

pubmed: 33004861
doi: 10.1038/s41598-020-72671-7
pii: 10.1038/s41598-020-72671-7
pmc: PMC7529897
doi:

Substances chimiques

Biomarkers 0
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16198

Subventions

Organisme : Marie Curie
ID : 778298
Pays : United Kingdom

Références

Abdossamadi, Z., Seyed, N. & Rafati, S. Mammalian host defense peptides and their implication on combating Leishmania infection. Cell. Immunol. 309, 23–31 (2016).
pubmed: 27729107 doi: 10.1016/j.cellimm.2016.10.001 pmcid: 27729107
Azizi, M. H., Bahadori, M., Dabiri, S., Meymandi, S. S. & Azizi, F. A history of Leishmaniasis in Iran from 19th century onward. Arch. Iran. Med. 19, 153 (2016).
pubmed: 26838089 pmcid: 26838089
Iantorno, S. A. et al. Gene expression in Leishmania is regulated predominantly by gene dosage. MBio 8, e01393-01317 (2017).
doi: 10.1128/mBio.01393-17
Norouzinezhad, F., Ghaffari, F., Norouzinejad, A., Kaveh, F. & Gouya, M. M. Cutaneous leishmaniasis in Iran: results from an epidemiological study in urban and rural provinces. Asian Pac. J. Trop. Biomed. 6, 614–619 (2016).
doi: 10.1016/j.apjtb.2016.05.005
Bamorovat, M. et al. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PLoS ONE 13, e0192236 (2018).
pubmed: 29415078 pmcid: 5802920 doi: 10.1371/journal.pone.0192236
Mirahmadi, H., Rezaee, N., Mehravaran, A., Heydarian, P. & Raeghi, S. Detection of species and molecular typing of Leishmania in suspected patients by targeting cytochrome b gene in Zahedan, southeast of Iran. Vet. World 11, 700 (2018).
pubmed: 29915511 pmcid: 5993770 doi: 10.14202/vetworld.2018.700-705
Rasti, S., Delavari, M., Arani, T. S. T. & Mousavi, S. G. A. Epidemiological and clinical study on the cutaneous leishmaniasis in Aran and Bidgol, center of Iran. Int. Arch. Health Sci. 5, 72 (2018).
doi: 10.4103/iahs.iahs_26_18
Ghatee, M. A. et al. Population structure of leishmania tropica causing anthroponotic cutaneous leishmaniasis in southern Iran by PCR-RFLP of kinetoplastid DNA. BioMed Res. Int. https://doi.org/10.1155/2018/6049198 (2018).
doi: 10.1155/2018/6049198 pubmed: 29984240 pmcid: 6011176
Khosravi, A. et al. Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994–2014. Iran. J. Parasitol. 12, 544 (2017).
pubmed: 29317879 pmcid: 5756304
Rostamian, M. & Niknam, H. M. Leishmania tropica: what we know from its experimental models. Adv. Parasitol. 104, 1–38 (2019).
pubmed: 31030767 doi: 10.1016/bs.apar.2018.11.001 pmcid: 31030767
Van der Auwera, G. & Dujardin, J.-C. Species typing in dermal leishmaniasis. Clin. Microbiol. Rev. 28, 265–294 (2015).
pubmed: 25672782 pmcid: 4402951 doi: 10.1128/CMR.00104-14
Krayter, L., Schnur, L. F. & Schönian, G. The genetic relationship between Leishmania aethiopica and Leishmania tropica revealed by comparing microsatellite profiles. PLoS ONE 10, e0131227 (2015).
pubmed: 26196393 pmcid: 4511230 doi: 10.1371/journal.pone.0131227
Rethi, B. & Eidsmo, L. FasL and TRAIL signaling in the skin during cutaneous leishmaniasis—implications for tissue immunopathology and infectious control. Front. Immunol. 3, 163 (2012).
pubmed: 22723798 pmcid: 3377931 doi: 10.3389/fimmu.2012.00163
van Henten, S. et al. Cutaneous leishmaniasis due to Leishmania aethiopica. EClinicalMedicine 6, 69–81 (2018).
pubmed: 31193672 doi: 10.1016/j.eclinm.2018.12.009 pmcid: 31193672
Hashemi, N. et al. PCR-RFLP diagnosis and characterization of Leishmania species causing human cutaneous leishmaniasis and evaluation of treatment times with glucantime in these patients. Trop. Biomed. 33, 689–696 (2016).
Kumar, R., Bumb, R. A. & Salotra, P. Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors. Immunology 130, 193–201 (2010).
pubmed: 20102417 pmcid: 2878464 doi: 10.1111/j.1365-2567.2009.03223.x
Kumar, R., Bumb, R. A. & Salotra, P. Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica. FEMS Immunol. Med. Microbiol. 57, 239–246 (2009).
pubmed: 19799628 doi: 10.1111/j.1574-695X.2009.00607.x pmcid: 19799628
Patino, L. H. & Ramírez, J. D. RNA-seq in kinetoplastids: a powerful tool for the understanding of the biology and host-pathogen interactions. Infect. Genet. Evol. 49, 273–282 (2017).
pubmed: 28179142 doi: 10.1016/j.meegid.2017.02.003 pmcid: 28179142
Amorim, C. F. et al. Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aax4204 (2019).
doi: 10.1126/scitranslmed.aax4204 pubmed: 31748229 pmcid: 7068779
Veras, P. S. T., Ramos, P. I. P. & de Menezes, J. P. B. In search of biomarkers for pathogenesis and control of leishmaniasis by global analyses of leishmania-infected macrophages. Front. Cell. Infect. Microbiol. 8, 326 (2018).
pubmed: 30283744 pmcid: 6157484 doi: 10.3389/fcimb.2018.00326
Christensen, S. M. et al. Meta-transcriptome profiling of the human-Leishmania braziliensis cutaneous lesion. PLoS Negl. Trop. Dis. 10, e0004992 (2016).
pubmed: 27631090 pmcid: 5025153 doi: 10.1371/journal.pntd.0004992
Masoudzadeh, N. et al. Leishmania tropica infected human lesions: whole genome transcription profiling. Acta Trop. 176, 236–241 (2017).
pubmed: 28842129 doi: 10.1016/j.actatropica.2017.08.016 pmcid: 28842129
Taslimi, Y. et al. A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis. PLoS Negl. Trop. Dis. 11, e0005750 (2017).
pubmed: 28704463 pmcid: 5526608 doi: 10.1371/journal.pntd.0005750
Dabirian, S. et al. Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate. PLoS Negl. Trop. Dis. https://doi.org/10.1371/journal.pntd.0002491 (2013).
doi: 10.1371/journal.pntd.0002491 pubmed: 24147170 pmcid: 3798388
Rana, T. et al. Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. J. Biol. Chem. 286, 6614–6626 (2011).
pubmed: 21149457 doi: 10.1074/jbc.M110.181735 pmcid: 21149457
Afrin, F., Khan, I. & Hemeg, H. A. Leishmania–host interactions—an epigenetic paradigm. Front. Immunol. https://doi.org/10.3389/fimmu.2019.00492 (2019).
doi: 10.3389/fimmu.2019.00492 pubmed: 30967861 pmcid: 6438953
Marr, A. K. et al. Leishmania donovani infection causes distinct epigenetic DNA methylation changes in host macrophages. PLoS Pathog. 10, e1004419 (2014).
pubmed: 25299267 pmcid: 4192605 doi: 10.1371/journal.ppat.1004419
Carlsen, E. et al. Permissive and protective roles for neutrophils in leishmaniasis. Clin. Exp. Immunol. 182, 109–118 (2015).
pubmed: 26126690 pmcid: 4608500 doi: 10.1111/cei.12674
Gupta, G., Oghumu, S. & Satoskar, A. R. Advances in Applied Microbiology Vol. 82, 155–184 (Elsevier, Amsterdam, 2013).
Polari, L. P. et al. Leishmania braziliensis infection enhances Toll-like receptors 2 and 4 expression and triggers TNF-α and IL-10 production in human cutaneous leishmaniasis. Front. Cell. Infect. Microbiol. https://doi.org/10.3389/fcimb.2019.00120 (2019).
doi: 10.3389/fcimb.2019.00120 pubmed: 31119102 pmcid: 6507514
Galgamuwa, L. S., Sumanasena, B., Iddawela, D., Wickramasinghe, S. & Yatawara, L. Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka. BMC Microbiol. 19, 14 (2019).
pubmed: 30642262 pmcid: 6332851 doi: 10.1186/s12866-018-1384-4
Stanifer, M. L., Pervolaraki, K. & Boulant, S. Differential regulation of type I and type III interferon signaling. Int. J. Mol. Sci. 20, 1445 (2019).
pmcid: 6471306 doi: 10.3390/ijms20061445
Handjani, F., Yousef, S. R., Saki, N. & Hamidizadeh, N. Interleukin-10 and interferon-γ levels in patients with cutaneous leishmaniasis treated with cryotherapy. Iran. J. Med. Sci. 42, 488 (2017).
pubmed: 29234182 pmcid: 5722967
Keesen, T. S. L. et al. CD4 (+) T cells defined by their Vb T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Clin. Exp. Immunol. 165, 338–351 (2011).
pubmed: 21726211 pmcid: 3170983 doi: 10.1111/j.1365-2249.2011.04430.x
Tuladhar, R., Natarajan, G. & Satoskar, A. R. Role of co-stimulation in leishmaniasis. Int. J. Biol. Sci. 7, 1382 (2011).
pubmed: 22110389 pmcid: 3221945 doi: 10.7150/ijbs.7.1382
Steinbuck, M. P. & Winandy, S. A review of notch processing with new insights into ligand-independent notch signaling in T-cells. Front. Immunol. 9, 1230 (2018).
pubmed: 29910816 pmcid: 5992298 doi: 10.3389/fimmu.2018.01230
Tindemans, I., Peeters, M. J. & Hendriks, R. W. Notch signaling in T helper cell subsets: instructor or unbiased amplifier?. Front. Immunol. 8, 419 (2017).
pubmed: 28458667 pmcid: 5394483 doi: 10.3389/fimmu.2017.00419
Fernandes, M. C. et al. Dual transcriptome profiling of Leishmania-infected human macrophages reveals distinct reprogramming signatures. MBio 7, e00027-e116 (2016).
pubmed: 27165796 pmcid: 4959658 doi: 10.1128/mBio.00027-16
Kaiser, A. Druggable targets in cyclic nucleotide signaling pathways in apicomplexan parasites and kinetoplastids against disabling protozoan diseases in humans. Int. J. Mol. Sci. 20, 138 (2019).
pmcid: 6337498 doi: 10.3390/ijms20010138
Chakraborty, A. et al. Wnt5a signaling promotes host defense against Leishmania donovani infection. J. Immunol. 199, 992–1002 (2017).
pubmed: 28659356 doi: 10.4049/jimmunol.1601927 pmcid: 28659356
Cakraborty, A., Maity, S. & Sen, M. Leishmaniasis—From Basic Research to the Field (IntechOpen, London, 2019).
Rastrojo, A. et al. Analysis by RNA-seq of transcriptomic changes elicited by heat shock in Leishmania major. Sci. Rep. 9, 6919 (2019).
pubmed: 31061406 pmcid: 6502937 doi: 10.1038/s41598-019-43354-9
Gerondakis, S. & Siebenlist, U. Roles of the NF-κB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2, a000182 (2010).
pubmed: 20452952 pmcid: 2857169 doi: 10.1101/cshperspect.a000182
Christensen, S. M. et al. Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis. PLoS Negl. Trop. Dis. 13, e0007152 (2019).
pubmed: 30845223 pmcid: 6405045 doi: 10.1371/journal.pntd.0007152
Isnard, A. et al. Impact of Leishmania infection on host macrophage nuclear physiology and nucleopore complex integrity. PLoS Pathog. 11, e1004776 (2015).
pubmed: 25826301 pmcid: 4380401 doi: 10.1371/journal.ppat.1004776
Moshrefi, M. et al. Tumor suppressor p53 induces apoptosis of host lymphocytes experimentally infected by Leishmania major, by activation of Bax and caspase-3: a possible survival mechanism for the parasite. Parasitol. Res. 116, 2159–2166 (2017).
pubmed: 28560572 doi: 10.1007/s00436-017-5517-8 pmcid: 28560572
Patel, K. R., Roberts, J. T. & Barb, A. W. Multiple variables at the leukocyte cell surface impact Fc γ receptor-dependent mechanisms. Front. Immunol. https://doi.org/10.3389/fimmu.2019.00223 (2019).
doi: 10.3389/fimmu.2019.00223 pubmed: 31921137 pmcid: 6927425
Pollara, J. & Tay, M. Z. Antibody-dependent cellular phagocytosis in antiviral immune responses. Front. Immunol. 10, 332 (2019).
pubmed: 30873178 pmcid: 6404786 doi: 10.3389/fimmu.2019.00332
Oualha, R. et al. Infection of human neutrophils with Leishmania infantum or Leishmania major strains triggers activation and differential cytokines release. Front. Cell. Infect. Microbiol. 9, 153 (2019).
pubmed: 31134162 pmcid: 6524560 doi: 10.3389/fcimb.2019.00153
Carlsen, E. D. et al. Interactions between neutrophils and Leishmania braziliensis amastigotes facilitate cell activation and parasite clearance. J. Innate Immun. 7, 354–363 (2015).
pubmed: 25766649 pmcid: 4485586 doi: 10.1159/000373923
Oghumu, S., Lezama-Dávila, C. M., Isaac-Márquez, A. P. & Satoskar, A. R. Role of chemokines in regulation of immunity against leishmaniasis. Exp. Parasitol. 126, 389–396 (2010).
pubmed: 20206625 pmcid: 3661772 doi: 10.1016/j.exppara.2010.02.010
Bahrami, F., Harandi, A. M. & Rafati, S. Biomarkers of cutaneous leishmaniasis. Front. Cell. Infect. Microbiol. 8, 222 (2018).
pubmed: 29998089 pmcid: 6029629 doi: 10.3389/fcimb.2018.00222
Pohin, M. et al. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation. Eur. J. Immunol. 46, 1737–1751 (2016).
pubmed: 27122058 doi: 10.1002/eji.201546216 pmcid: 27122058
Huguier, V. et al. Oncostatin M exerts a protective effect against excessive scarring by counteracting the inductive effect of TGFβ1 on fibrosis markers. Sci. Rep. 9, 2113 (2019).
pubmed: 30765798 pmcid: 6376164 doi: 10.1038/s41598-019-38572-0
Rabeony, H. et al. Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M. PLoS ONE 9, e101937 (2014).
pubmed: 25010647 pmcid: 4092099 doi: 10.1371/journal.pone.0101937
Azevedo, E. et al. Interactions between Leishmania braziliensis and macrophages are dependent on the cytoskeleton and myosin Va. J. Parasitol. Res. https://doi.org/10.1155/2012/275436 (2012).
doi: 10.1155/2012/275436 pubmed: 22792440 pmcid: 3391898
DaMata, J. P. et al. Distinct macrophage fates after in vitro infection with different species of Leishmania: induction of apoptosis by Leishmania (Leishmania) amazonensis, but not by Leishmania (Viannia) guyanensis. PLoS ONE 10, e0141196 (2015).
pubmed: 26513474 pmcid: 4626090 doi: 10.1371/journal.pone.0141196
Bydoun, M., Sterea, A., Weaver, I. C., Bharadwaj, A. D. & Waisman, D. M. A novel mechanism of plasminogen activation in epithelial and mesenchymal cells. Sci. Rep. 8, 14091 (2018).
pubmed: 30237490 pmcid: 6148250 doi: 10.1038/s41598-018-32433-y
Oliveira, F. et al. Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 85, 70–73 (2011).
pubmed: 21734128 pmcid: 3122347 doi: 10.4269/ajtmh.2011.10-0680
Xu, G. et al. LIGHT is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J. Immunol. 179, 6901–6909 (2007).
pubmed: 17982081 doi: 10.4049/jimmunol.179.10.6901 pmcid: 17982081
Stanley, A. C. et al. Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection. PLoS Pathog. https://doi.org/10.1371/journal.ppat.1002279 (2011).
doi: 10.1371/journal.ppat.1002279 pubmed: 21998581 pmcid: 3188526
Tasew, G. et al. Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration. PLoS Negl. Trop. Dis. 4, e844 (2010).
pubmed: 20967287 pmcid: 2953481 doi: 10.1371/journal.pntd.0000844
Griffiths, C., Barker, J., Bleiker, T., Chalmers, R. & Creamer, D. Rook’s Textbook of Dermatology (Wiley, New York, 2016).
doi: 10.1002/9781118441213
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 pmcid: 23104886 doi: 10.1093/bioinformatics/bts635
Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
pubmed: 25260700 pmcid: 25260700 doi: 10.1093/bioinformatics/btu638
R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. https://www.R-project.org (2018).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 25516281 doi: 10.1186/s13059-014-0550-8
Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284–287 (2012).
pubmed: 22455463 pmcid: 3339379 doi: 10.1089/omi.2011.0118
Yu, G. & He, Q.-Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol. BioSyst. 12, 477–479 (2016).
pubmed: 26661513 doi: 10.1039/C5MB00663E pmcid: 26661513
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545–15550 (2005).
pubmed: 16199517 doi: 10.1073/pnas.0506580102 pmcid: 16199517
Yu, G., Wang, L.-G., Yan, G.-R. & He, Q.-Y. DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics 31, 608–609 (2014).
pubmed: 25677125 doi: 10.1093/bioinformatics/btu684 pmcid: 25677125
Bhandage, A. K. et al. GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4+ T cells and is immunosuppressive in type 1 diabetes. EBioMedicine 30, 283–294 (2018).
pubmed: 29627388 pmcid: 5952354 doi: 10.1016/j.ebiom.2018.03.019
Gunn, B. M. et al. Survivors of Ebola virus disease develop polyfunctional antibody responses. J. Infect. Dis. 221, 156–161 (2020).
pubmed: 31301137 doi: 10.1093/infdis/jiz364 pmcid: 31301137
Šidák, Z. Rectangular confidence regions for the means of multivariate normal distributions. J. Am. Stat. Assoc. 62, 626–633 (1967).
Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639–1645 (2009).
pubmed: 2752132 pmcid: 2752132 doi: 10.1101/gr.092759.109

Auteurs

Nasrin Masoudzadeh (N)

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

Malin Östensson (M)

Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Josefine Persson (J)

Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Vahid Mashayekhi Goyonlo (V)

Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Christopher Agbajogu (C)

Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Yasaman Taslimi (Y)

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

Reza Erfanian Salim (R)

Noor Eye Hospital, Tehran, Iran.

Farnaz Zahedifard (F)

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

Amir Mizbani (A)

ETH Zurich, Zurich, Switzerland.

Housein Malekafzali Ardekani (H)

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.

Bronwyn M Gunn (BM)

Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA, 02139, USA.
Paul G. Allen School of Global Animal Health, Washington State University, Pullman, WA, 99164, USA.

Sima Rafati (S)

Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran. s_rafati@yahoo.com.

Ali M Harandi (AM)

Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. ali.harandi@microbio.gu.se.
Vaccine Evaluation Center, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, Canada. ali.harandi@microbio.gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH